Delivery Order SPE2DB24D2101-SPE2DB25FKPPA
Award Date 9/15/25
Potential Completion Date 10/6/25
Potential Value $5.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $42,647.60 on August 14, 2025, for the supply of Herceptin 150 mg vials, with a completion date of September 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Herceptin 150 mg vials, valued at $10,681.68, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Herceptin is a critical biopharmaceutical used in cancer treatment, particularly for...
- The Defense Department's Medical Supply Chain, a division of the Defense Logistics Agency, awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Herceptin 150 mg vials. This firm fixed-price delivery order, valued at $26,704.20, is scheduled for completion by September 30, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The award was competitively procured with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $74,573.96 to AmerisourceBergen Drug Corp for the supply of Herceptin Hylecta 600mg injections (10,000 5mL units). This firm fixed-price delivery order, issued on August 6, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside competitive award. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Herceptin Hylecta is a HER2-targeted therapeutic...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $5,301.18 delivery order is for the supply of 4564368088 HERCEPTIN 150 MG Vials. The contract has a firm fixed price and an ultimate completion date of May 14, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is for the delivery of the pharmaceutical product Herceptin 150 mg vials. The $17,670.60 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that provides logistics and acquisition services to the U.S. Armed Forces. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00, which serves...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the prime contractor, for the provision of 150 mg vials of the pharmaceutical drug Herceptin. The delivery order has a completion date of March 22, 2024 and a potential value of $8,835.30. Amerisourcebergen Drug Corp, a for-profit organization, is a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,650.59 contract is for the delivery of 150 mg vials of the cancer drug Herceptin. The contract has a completion date of June 28, 2024 and is a firm fixed price, delivery order. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of HERCEPTIN 150 MG VIALS. The contract is a Delivery Order with a Firm Fixed Price of $2,670.42 and a performance period extending until July 30, 2025. It was awarded on July 9, 2025 by the Defense Logistics Agency (DLA), which serves as the Defense or Civilian agency for this contract. The contract is not set aside and is open to full and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Herceptin 150 mg vials, a specialty pharmaceutical product, to support military treatment programs and facilities. The firm fixed price delivery order has a potential value of $4,612.10 and a completion date of January 12, 2024. No set-aside designation was used for this award....